• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性巨细胞病毒感染且羊水穿刺结果阴性的婴儿的新生儿期和长期结局:系统评价和荟萃分析。

Neonatal and long-term outcomes of infants with congenital cytomegalovirus infection and negative amniocentesis: systematic review and meta-analysis.

机构信息

Second Department of Obstetrics and Gynaecology, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

EA Fetus, Paris Descartes University, University of Paris, Paris, France.

出版信息

Ultrasound Obstet Gynecol. 2023 Feb;61(2):158-167. doi: 10.1002/uog.26128.

DOI:10.1002/uog.26128
PMID:36412976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10107880/
Abstract

OBJECTIVE

Cytomegalovirus (CMV) DNA is detectable in the amniotic fluid collected by amniocentesis in cases in which the fetus has been infected. However, cases of congenital neonatal CMV infection with a negative amniocentesis result have also been reported in the literature. The aim of the present study was to compare pregnancies with a negative amniocentesis result to those with a positive amniocentesis result in terms of incidence of fetal insult and long-term sequelae.

METHODS

Observational studies that included pregnant women with CMV infection who underwent amniocentesis and that reported their results together with neonatal and/or long-term outcomes of the offspring were included. The risk of bias in included studies was assessed using the Newcastle-Ottawa Scale. The rate of severe symptoms at birth, defined as neurological symptoms or multiorgan involvement at birth, and the rate of severe sensorineural hearing loss (SNHL) and/or neurodevelopmental impairment at follow-up were the main outcomes of the study. The secondary outcome was the rate of pregnancy termination due to the presence of CMV-associated central nervous system (CNS) findings or multiorgan involvement on ultrasound/magnetic resonance imaging (MRI).

RESULTS

Seven studies were included in the systematic review and meta-analysis. The pooled false-negative rate of amniocentesis was 8.0% (95% CI, 5.0-13.0%). The pooled rate of severe symptoms at birth was 0.0% (95% CI, 0.0-1.0%; I  = 0%) in fetuses with a negative amniocentesis result and 22.0% (95% CI, 11.0-38.0%; I  = 75%) in those with a positive amniocentesis result. The pooled odds ratio (OR) was 0.03 (95% CI, 0.01-0.10; I  = 0%). The pooled rate of severe SNHL and/or neurodevelopmental impairment at follow-up in fetuses with a negative amniocentesis result was 0.0% (95% CI, 0.0-1.0%; I  = 0%) and, in those with a positive amniocentesis result, it was 14.0% (95% CI, 7.0-26.0%; I  = 64%). The pooled OR was 0.04 (95% CI, 0.01-0.14; I  = 0%). The pooled rate of pregnancy termination due to the presence of CMV-associated CNS findings or multiorgan involvement on ultrasound/MRI was 0.0% (95% CI, 0.0-2.0%; I  = 0%) in fetuses with a negative amniocentesis result and 20.0% (95% CI, 10.0-36.0%; I  = 82%) in those with a positive amniocentesis result. The pooled OR was 0.03 (95% CI, 0.01-0.08; I  = 0%). A subgroup analysis including only pregnancies with primary CMV infection and a sensitivity analysis including only prospective studies were carried out, showing very similar results to those of the main analysis.

CONCLUSION

A negative amniocentesis result in pregnant women with CMV infection ensures lack of fetal insult and long-term sequelae to the child, even if transmission has occurred. © 2022 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f690/10107880/9e025add903c/UOG-61-158-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f690/10107880/413571212a4a/UOG-61-158-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f690/10107880/7cf6d2740e3d/UOG-61-158-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f690/10107880/12b13edd4828/UOG-61-158-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f690/10107880/9e025add903c/UOG-61-158-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f690/10107880/413571212a4a/UOG-61-158-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f690/10107880/7cf6d2740e3d/UOG-61-158-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f690/10107880/12b13edd4828/UOG-61-158-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f690/10107880/9e025add903c/UOG-61-158-g002.jpg
摘要

目的

在胎儿已感染的情况下,通过羊膜穿刺术收集的羊水可检测出巨细胞病毒 (CMV) DNA。然而,文献中也报道了一些先天性新生儿 CMV 感染且羊膜穿刺术结果为阴性的病例。本研究旨在比较羊膜穿刺术结果为阴性和阳性的妊娠病例,以评估胎儿损伤和长期后遗症的发生率。

方法

纳入了接受羊膜穿刺术并报告了结果以及新生儿和/或后代长期结局的 CMV 感染孕妇的观察性研究。使用纽卡斯尔-渥太华量表评估纳入研究的偏倚风险。主要研究结果是出生时严重症状的发生率,定义为出生时存在神经症状或多器官受累;以及出生后严重感觉神经性听力损失 (SNHL) 和/或神经发育障碍的发生率。次要结局是由于存在与 CMV 相关的中枢神经系统 (CNS) 发现或超声/磁共振成像 (MRI) 显示多器官受累而终止妊娠的发生率。

结果

系统评价和荟萃分析纳入了 7 项研究。羊膜穿刺术的假阴性率为 8.0%(95%置信区间,5.0-13.0%)。羊膜穿刺术结果为阴性的胎儿中,出生时存在严重症状的发生率为 0.0%(95%置信区间,0.0-1.0%;I²=0%),而羊膜穿刺术结果为阳性的胎儿中,该发生率为 22.0%(95%置信区间,11.0-38.0%;I²=75%)。汇总比值比(OR)为 0.03(95%置信区间,0.01-0.10;I²=0%)。羊膜穿刺术结果为阴性的胎儿中,出生后存在严重 SNHL 和/或神经发育障碍的发生率为 0.0%(95%置信区间,0.0-1.0%;I²=0%),而羊膜穿刺术结果为阳性的胎儿中,该发生率为 14.0%(95%置信区间,7.0-26.0%;I²=64%)。汇总 OR 为 0.04(95%置信区间,0.01-0.14;I²=0%)。羊膜穿刺术结果为阴性的胎儿中,由于存在与 CMV 相关的 CNS 发现或多器官受累而终止妊娠的发生率为 0.0%(95%置信区间,0.0-2.0%;I²=0%),而羊膜穿刺术结果为阳性的胎儿中,该发生率为 20.0%(95%置信区间,10.0-36.0%;I²=82%)。汇总 OR 为 0.03(95%置信区间,0.01-0.08;I²=0%)。进行了仅包括原发性 CMV 感染的亚组分析和仅包括前瞻性研究的敏感性分析,结果与主要分析非常相似。

结论

CMV 感染孕妇的羊膜穿刺术结果为阴性可确保胎儿无损伤和长期后遗症,即使已经发生了传播。© 2022 作者。约翰威立父子公司出版的《超声妇产科杂志》由国际妇产科超声学会代表出版。

相似文献

1
Neonatal and long-term outcomes of infants with congenital cytomegalovirus infection and negative amniocentesis: systematic review and meta-analysis.先天性巨细胞病毒感染且羊水穿刺结果阴性的婴儿的新生儿期和长期结局:系统评价和荟萃分析。
Ultrasound Obstet Gynecol. 2023 Feb;61(2):158-167. doi: 10.1002/uog.26128.
2
Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis.产前伐昔洛韦治疗先天性巨细胞病毒感染的有效性和安全性:系统评价和荟萃分析。
Ultrasound Obstet Gynecol. 2023 Apr;61(4):436-444. doi: 10.1002/uog.26136.
3
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
4
Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more).足月(37周及以上)胎膜早破时计划早产与期待治疗(等待)的比较。
Cochrane Database Syst Rev. 2017 Jan 4;1(1):CD005302. doi: 10.1002/14651858.CD005302.pub3.
5
Congenital cytomegalovirus infection and brain injury in a newborn following maternal non-primary infection: case report of an unexpected diagnosis.母亲非原发性感染后新生儿先天性巨细胞病毒感染与脑损伤:意外诊断的病例报告
Ital J Pediatr. 2025 Jun 21;51(1):197. doi: 10.1186/s13052-025-02017-4.
6
Congenital anomaly and perinatal outcome following blastocyst- vs cleavage-stage embryo transfer: systematic review and network meta-analysis.囊胚期与卵裂期胚胎移植后先天畸形与围产儿结局:系统评价与网络荟萃分析。
Ultrasound Obstet Gynecol. 2023 Jan;61(1):12-25. doi: 10.1002/uog.26019.
7
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低艾滋病毒感染母婴传播风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2011 Jul 6(7):CD003510. doi: 10.1002/14651858.CD003510.pub3.
8
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低人类免疫缺陷病毒感染母婴传播风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2007 Jan 24(1):CD003510. doi: 10.1002/14651858.CD003510.pub2.
9
Outcome following laser surgery of twin-twin transfusion syndrome complicated by selective fetal growth restriction: systematic review and meta-analysis.激光手术治疗双胎输血综合征合并选择性胎儿生长受限的结局:系统评价和荟萃分析。
Ultrasound Obstet Gynecol. 2023 Sep;62(3):320-327. doi: 10.1002/uog.26252.
10
Amniocentesis and chorionic villus sampling for prenatal diagnosis.用于产前诊断的羊膜穿刺术和绒毛取样。
Cochrane Database Syst Rev. 2017 Sep 4;9(9):CD003252. doi: 10.1002/14651858.CD003252.pub2.

引用本文的文献

1
Is Neonatal Viremia a Possible Predictor of the Timing of Maternal Infection in Asymptomatic Congenital Cytomegalovirus Infection? A Retrospective Study.新生儿病毒血症是否是无症状先天性巨细胞病毒感染中母体感染时间的潜在预测指标?一项回顾性研究。
J Pers Med. 2025 Apr 24;15(5):165. doi: 10.3390/jpm15050165.
2
Prevalence and timing of prenatal ultrasound findings in cytomegalovirus-infected pregnancies.巨细胞病毒感染妊娠中产前超声检查结果的患病率及出现时间
Acta Obstet Gynecol Scand. 2025 Feb;104(2):302-308. doi: 10.1111/aogs.15018. Epub 2024 Dec 1.
3
Audiological and Vestibular Follow-Up for Children with Congenital Cytomegalovirus Infection: From Current Limitations to Future Directions.

本文引用的文献

1
Prevalence, Outcome, and Prevention of Congenital Cytomegalovirus Infection in Neonates Born to Women With Preconception Immunity (CHILd Study).先天性巨细胞病毒感染在有孕前免疫的妇女所生新生儿中的流行率、结局和预防(CHILd 研究)。
Clin Infect Dis. 2023 Feb 8;76(3):513-520. doi: 10.1093/cid/ciac482.
2
First-trimester diagnosis of congenital cytomegalovirus infection after maternal primary infection in early pregnancy: feasibility study of viral genome amplification by PCR on chorionic villi obtained by CVS.早孕期原发感染孕妇绒毛活检病毒基因组 PCR 扩增技术用于先天性巨细胞病毒感染的早期诊断:可行性研究。
Ultrasound Obstet Gynecol. 2021 Apr;57(4):568-572. doi: 10.1002/uog.23608. Epub 2021 Mar 9.
3
先天性巨细胞病毒感染儿童的听力学和前庭功能随访:从当前局限到未来方向
Children (Basel). 2024 Oct 1;11(10):1211. doi: 10.3390/children11101211.
4
Results of mother-to-child transmission in hepatitis B-positive mothers who underwent amniocentesis.乙肝阳性母亲行羊膜腔穿刺术的母婴传播结果。
BMC Infect Dis. 2024 Sep 11;24(1):957. doi: 10.1186/s12879-024-09848-2.
5
Neonatal and short-term outcome after late vertical transmission in congenital CMV-infected fetuses following primary first-trimester maternal seroconversion.原发感染孕妇于妊娠早期初次血清学转换后发生的迟发垂直传播对先天性巨细胞病毒感染胎儿的新生儿期及短期结局的影响。
BMJ Paediatr Open. 2024 Sep 10;8(1):e002773. doi: 10.1136/bmjpo-2024-002773.
6
Tissue engineering strategies for spiral ganglion neuron protection and regeneration.用于螺旋神经节神经元保护和再生的组织工程策略
J Nanobiotechnology. 2024 Jul 31;22(1):458. doi: 10.1186/s12951-024-02742-8.
7
Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI).欧洲先天性感染倡议(ECCI)关于先天性巨细胞病毒感染产前、新生儿期和产后管理的共识建议。
Lancet Reg Health Eur. 2024 Apr 1;40:100892. doi: 10.1016/j.lanepe.2024.100892. eCollection 2024 May.
8
Cytomegalovirus and Pregnancy: A Narrative Review.巨细胞病毒与妊娠:一篇叙述性综述。
J Clin Med. 2024 Jan 22;13(2):640. doi: 10.3390/jcm13020640.
9
Congenital cytomegalovirus infection: the state of the art and future perspectives.先天性巨细胞病毒感染:现状与未来展望
Front Pediatr. 2023 Nov 16;11:1276912. doi: 10.3389/fped.2023.1276912. eCollection 2023.
10
Neurodevelopmental outcomes in congenital and perinatal infections.先天性和围产期感染的神经发育结果。
Curr Opin Infect Dis. 2023 Oct 1;36(5):405-413. doi: 10.1097/QCO.0000000000000946. Epub 2023 Jul 19.
Timing of primary maternal cytomegalovirus infection and rates of vertical transmission and fetal consequences.
原发性巨细胞病毒感染的时机及垂直传播率和胎儿结局。
Am J Obstet Gynecol. 2020 Dec;223(6):870-883.e11. doi: 10.1016/j.ajog.2020.05.038. Epub 2020 May 24.
4
Is it time for routine prenatal serological screening for congenital cytomegalovirus?是否到了常规产前血清学筛查先天性巨细胞病毒的时候了?
Prenat Diagn. 2020 Dec;40(13):1671-1680. doi: 10.1002/pd.5757. Epub 2020 Jul 27.
5
ISUOG Practice Guidelines: role of ultrasound in congenital infection.国际妇产科超声学会(ISUOG)实践指南:超声在先天性感染中的作用
Ultrasound Obstet Gynecol. 2020 Jul;56(1):128-151. doi: 10.1002/uog.21991. Epub 2020 May 13.
6
Cytomegalovirus infection during pregnancy: state of the science.巨细胞病毒感染的孕妇:科学现状。
Am J Obstet Gynecol. 2020 Sep;223(3):330-349. doi: 10.1016/j.ajog.2020.02.018. Epub 2020 Feb 24.
7
Clinical Implications for Children Born With Congenital Cytomegalovirus Infection Following a Negative Amniocentesis.巨细胞病毒感染阴性羊水穿刺后出生的先天性巨细胞病毒感染患儿的临床意义。
Clin Infect Dis. 2016 Jul 1;63(1):33-8. doi: 10.1093/cid/ciw237. Epub 2016 Apr 24.
8
Editorial Commentary: Amniocentesis for Detection of Congenital Cytomegalovirus Infection: What Is the Point?编者按:羊水穿刺检测先天性巨细胞病毒感染:意义何在?
Clin Infect Dis. 2016 Jul 1;63(1):39-40. doi: 10.1093/cid/ciw238. Epub 2016 Apr 24.
9
In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study.在一项多中心、开放标签的II期研究中,使用伐昔洛韦对先天性巨细胞病毒感染进行宫内治疗。
Am J Obstet Gynecol. 2016 Oct;215(4):462.e1-462.e10. doi: 10.1016/j.ajog.2016.04.003. Epub 2016 Apr 13.
10
A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome.238 例妊娠原发性巨细胞病毒感染的系列病例:描述和结局。
Prenat Diagn. 2013 Aug;33(8):751-8. doi: 10.1002/pd.4118. Epub 2013 May 1.